Announcements Trials

Browse Landscape

Phase

Phase NA 15 Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7 Lymphoid 2 Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Ovarian Neoplasms 1 Motor Activity 1 Fatigue 1 Body Weight 1

Interventions

Paclitaxel 150 Carboplatin 110 Cisplatin 94 Bevacizumab 42 Topotecan 39 Gemcitabine 38 liposomal doxorubicin 34 Radiotherapy 29 Doxorubicin 27 Brachytherapy 26 Taxes 24 pembrolizumab 20 olaparib 20 Drug Therapy 20 Hyperthermic Intraperitoneal Chemotherapy 16 Chemotherapy, Adjuvant 16 human papillomavirus vaccine, L1 type 16, 18 15 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14 Docetaxel 13 Neoadjuvant Therapy 12 Platinum 10 niraparib 9 Radiation 9 1,2-diaminocyclohexaneplatinum II citrate 9 Vaccines, Synthetic 8 Surgical Procedures, Operative 8 atezolizumab 7 Specimen Handling 7 Papillomavirus Vaccines 7 Letrozole 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Exercise × Gynecologic × Clear all

NCT02107066 2018-04-20

WALC

Yale University

Phase 3 Completed

Body Weight, Fatigue, Motor Activity, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡